2025 Ketamine Practitioner Intelligence Research Report
What are ketamine practitioner's biggest pain points? Our 2025 Ketamine Practitioner Intelligence Research Report breaks it down.
Read More
Historic: Texas Invests $50 Million into Ibogaine Research
Texas has taken a bold step in mental health research by allocating $50 million to fund clinical trials of ibogaine.
Read More
Positive Data Shows Promise of 5-MeO-DMT in Patients When Used With SSRIs
This trial marks a significant departure and may reshape how clinicians combine traditional antidepressants and psychedelic therapy.
Read More
FDA Official Signals New Support for Psychedelic Therapies
FDA Commissioner Martin Makary recently signaled that reviews for psychedelic therapies could soon accelerate.
Read More
Florida Moves to Criminalize Psychedelic Mushroom Spores
Governor DeSantis confirmed he plans to sign a bill that would criminalize psychedelic mushroom spores in Florida.
Read More
Ketamine Study Yields Surprising Findings That Could Change Depression Treatment
A new study from Stanford University has uncovered unexpected results about ketamine’s role in treating depression.
Read More
Psychedelics May Improve Mental Health by Targeting Inflammation, Study Suggests
Researchers found that psychedelics may reduce inflammation in the brain and body by altering gene activity in immune cells.
Read More
Spravato Nasal Spray to Be Subsidized in Australia for Treatment Resistant Depression
The Australian government has announced that Spravato will be added to the Pharmaceutical Benefits Scheme starting July 1.
Read More
VA Secretary Signals Openness to Psychedelic and Alternative Treatments
The VA will explore new treatment options, including psychedelic therapy, according to recent comments from VA Secretary Doug Collins.
Read More
Psychedelics Show Promise in Reducing Chronic Pain and Opioid Dependence
An analysis in Psychology Today suggests patients may find using psychedelics for pain may offer significant benefits.
Read More